ArticleCell systems2026
Quantifying protein unfolding kinetics with a high-throughput microfluidic platform.
Article in Cell systems, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- ADAPT-M: a workflow for rapid, quantitative in vitro measurements of enriched protein libraries.Nature communications · 2026Article
- ADAPT-M: A workflow for rapid, quantitativebioRxiv : the preprint server for biology · 2025Article
- Structural Characterisation of TetR/AcrR Regulators inInternational journal of molecular sciences · 2025Article
Corrections and comments
- Update of
Authors and funding
4 authors.
Funding
Abstract
Even after folding, proteins sample unfolded intermediates at risk of irreversible alteration (e.g., via proteolysis, aggregation, or posttranslational modification). Thus, kinetic stability impacts protein lifetime and abundance. However, we have very few measurements of unfolding rates, largely due to technical challenges. To address this, we developed SPARKfold (simultaneous proteolysis assay revealing kinetics of folding), a microfluidic platform to express, purify, and measure unfolding rate constants at high throughput via native proteolysis. We applied SPARKfold to determine unfolding rate constants for 1,104 protein samples comprising 31 dihydrofolate reductase orthologs with up to 78 chamber replicates each, providing statistical power to resolve subtle effects. SPARKfold rate constants for 5 constructs agreed with traditional measurements across a 150-fold range and provided information about the folding transition state via φ analysis. In future work, SPARKfold can reveal mutations that drive misfolding and aggregation and enable the rational design of kinetically hyperstable variants for industrial use. A record of this paper's transparent peer review process is included in the supplemental information.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.